Benzinga's Top Pre-Market Gainers

Intermec IN moved up 24.37% to $9.90 in the pre-market session. Honeywell International HON announced its plans to buy Intermec for $600 million. Cyclacel Pharmaceuticals CYCC soared 6.98% to $6.90 in the pre-market trading. Cyclacel Pharmaceuticals announced updated survival data from the pilot study and lead-in phase of SEAMLESS Phase 3 study. Celldex Therapeutics CLDX added 6.88% to $5.90 in the pre-market session. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer. Ingersoll-Rand Plc IR surged 2.28% to $49.80 in the pre-market session. Ingersoll-Rand announced its plans to spin off its security division.